Form 4: Firefly Neuroscience Director DeCaprio Acquires Deferred Stock Units
SEC Form 4 Filing
David DeCaprio, a director at Firefly Neuroscience, was granted 16,667 Deferred Stock Units (DSUs) under the company's 2024 Long-Term Incentive Plan.
Summary
- On March 10, 2025, David DeCaprio, a director of Firefly Neuroscience, Inc., was granted 16,667 Deferred Stock Units (DSUs) under the Issuer's 2024 Long-Term Incentive Plan.
- 8,333 DSUs vested immediately on the grant date.
- An additional 4,167 DSUs will vest on June 10, 2025, and another 4,167 DSUs will vest on September 10, 2025.
- Each DSU represents a contingent right to receive one share of Firefly Neuroscience's common stock.
Sentiment
Score: 7
Explanation: The document reflects a standard compensation practice, suggesting stability and alignment of interests. The vesting schedule indicates a long-term commitment.
Positives
- The grant of DSUs to a director aligns their interests with those of the shareholders.
- The vesting schedule incentivizes continued service and contribution to the company.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the DSUs.
Industry Context
Grants of stock options and restricted stock units are a common way to compensate directors and align their interests with shareholders in the biotechnology industry.
Comparison to Industry Standards
- Director compensation packages vary widely across the biotechnology industry depending on company size, stage of development, and board responsibilities.
- Comparing Firefly Neuroscience's director compensation to companies like Biogen, Amgen, or smaller peers would provide a better understanding of its relative competitiveness.
- Stock options and restricted stock units are common components of director compensation packages in the biotech industry, often vesting over a multi-year period.
Stakeholder Impact
- The grant of DSUs aligns the director's interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.
- Employees may view the director's compensation as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Reporting Person was granted 16,667 DSUs under the Issuer's 2024 Long-Term Incentive Plan; 8,333 DSUs vested immediately. |
| 06/10/2025 | 4,167 DSUs will vest. |
| 09/10/2025 | 4,167 DSUs will vest. |
| 03/12/2025 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.